Stateside's Canadian Microcap Board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: statesidereport	3/29/2016 10:37:27 AM
	of 1728

The stock should get more attention in April from US investors: BriaCell will present a research study on the aforementioned research, mechanism of action of its lead cancer vaccine BriaVax, at the annual American Association for Cancer Research (AACR) meeting in New Orleans on April 18, 2016. The study, a molecular analyses of both BriaVax and blood specimens from patients treated therewith, identified a gene signature potentially explaining why a clinical trial subject responded to BriaVax with exceptionally strong regression of even stage IV, metastatic tumours, including brain metastases (reported by Wiseman and Kharazi, Breast J., 2006; 12(5):475 to 480). The abstract of the company's AACR meeting presentation is available on-line.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next